Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MITRAL STENOSIS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,063 records · Page 59Linked to original sources
PubMed1978

Mitral stenosis in Whipple's disease.

A patient who died of Whipple's disease had moderate mitral stenosis with large firm yellow vegetations on the contact area of the mitral leaflets. Light microsocopy showed PAS positive macrophages within the thickened cusps and overlying vegetations. Negative images of rod-shaped bodies were visible in the cytoplasm of the histiocytes. No Aschoff bodies were seen, and there was no history of rheumatic fever. The findings in this patient lend support to the concept that chronic rheumatic type valvar deformity may result from a persistent intrinsic infectious agent.

Humans↗
PubMed1989

Influence of mitral valve morphology on double-balloon catheter balloon valvuloplasty in patients with mitral stenosis. Analysis of factors predicting immediate and 3-month results.

To determine if mitral valve morphology influences the results of double-balloon catheter balloon valvuloplasty (CBV) for mitral stenosis, two-dimensional echocardiography was performed in 33 patients before CBV. The two-dimensional echocardiographic features of leaflet motion, leaflet thickness, subvalvular disease, and commissural calcium and 14 pre-CBV clinical and hemodynamic variables were then correlated to the immediately post-CBV mitral valve area (MVA). At 3 months after CBV, the two-dimensional echocardiographic features of patients with a 25% or greater decrease in MVA were analyzed to determine whether mitral valve morphology had influenced early results. Leaflet motion had a significant relation with the immediately post-CBV MVA (r = 0.67, y = 4.5x + 0.29, and SEE = 0.45). Leaflet thickness had a weak and negative relation (r = -0.48, y = -0.17x + 2.6, and SEE = 0.53) with the immediately post-CBV MVA. Subvalvular disease and commissural calcium had no significant relation to the immediately post-CBV MVA. When leaflet motion and leaflet thickness were considered as grades of mild, moderate, and severe and assigned a score of 0-2, patients with more severe disease (total score, 3 or 4) had a significant lower MVA immediately after CBV (1.4 +/- 0.4 cm2) than patients with moderate disease (score, 1-2; MVA, 2.0 +/- 0.5 cm2; p less than 0.05) or mild disease (score, 0; MVA, 2.6 +/- 0.6 cm2; p less than 0.05). In 96% of patients with a total score of 0-2, the immediately post-CBV MVA was more than 1.4 cm2, whereas only 29% of patients with a total score of 3-4 had an immediately post-CBV MVA of more than 1.4 cm2. Analysis of all two-dimensional echocardiographic features showed that leaflet motion score had the strongest influence on the post-CBV MVA (p less than 0.001). When all two-dimensional echocardiographic, clinical, and hemodynamic variables were included, leaflet motion, effective balloon dilating area, and cardiac output were the strongest predictors of the immediate post-CB MVA.(ABSTRACT TRUNCATED AT 400 WORDS)

Adult↗
PubMed1986

Extent of mitral calcific deposits determined by cineangiography in mitral stenosis and their effect on valve motion, hemodynamics and clinical signs.

The relation between the degree of leaflet calcium in a stenotic mitral valve and several parameters of valve mobility, hemodynamics and clinical signs was determined in 105 patients with relatively pure mitral stenosis (MS). The amount of mitral valve calcific deposits was determined by grading cineangiograms. Compared to 71 patients with no or minimal valvular calcium, the 23 patients with heavy valve leaflet calcium were significantly older, more likely to be men and more likely to be in atrial fibrillation. These patients also had a significant reduction of valve mobility in that their M-mode measurements of valve excursion and rate of valve opening were significantly reduced compared to those of patients without heavy valvular calcium. Two-dimensional echocardiograms also documented a significant reduction in valve mobility and progressive restriction in doming of the anterior mitral leaflet as the level of calcium increased. The prevalence of an opening snap was significantly decreased in patients with heavy vs no or light valvular calcium, and patients without an opening snap had reduced valve mobility. However, a considerable number of patients with moderate to heavy valve calcium retained an opening snap.

Adult↗
PubMed2000

Immediate effect of balloon valvuloplasty on hemostatic changes in mitral stenosis.

This study was conducted to assess right and left atrial hemostatic function in patients with mitral stenosis (MS) and to investigate the immediate effect of balloon mitral valvuloplasty (BMV) on hemostatic function. BMV was performed in 28 patients with MS (age 29 +/- 8 years) who had sinus rhythm and no left atrial (LA) thrombus. Right and left atrial biochemical markers of platelet activity (platelet factor 4 [PF4] and B thromboglobulin [BTG]), coagulation (thrombin-antithrombin III complex [TAT]), and fibrinolytic activity (D-dimer) were measured before and 30 minutes after BMV. Right atrial levels of these markers were also measured in 20 control subjects. Compared with control subjects, patients with MS had higher right atrial levels of PF4 (30 +/- 15 vs 5 +/- 2 IU/ml), BTG (231 +/- 53 vs 30 +/- 8 IU/ml), TAT (7 +/- 4 vs 2 +/- 0.3 microg/L), and D-dimer (380 +/- 145 vs 160 +/- 35 ng/ml, p < 0.0001 in all). TAT levels were higher in the left atrium than in the right atrium of patients before BMV (8 +/- 4 vs 7 +/- 4 microg/L, p < 0.0001). BMV was successful (final mitral valve area > or = 1.5 cm2 and > or = 50% increase of the initial valve area) in all patients. There was a significant reduction of LA levels of PF4 (35 +/- 8 to 26 +/- 9 IU/ml, p < 0.0001), BTG (225 +/- 41 to 196 +/- 28 IU/ml, p < 0.001), and TAT (10 +/- 5 to 7 +/- 1 microg/L, p < 0.05) in the 16 patients with LA pressure < 10 mm Hg after BMV, whereas these markers were not reduced in the 12 patients with left atrial pressure > or = 10 mm Hg after BMV. These data indicate that platelet function, coagulation status, and fibrinolytic activity are increased regionally in the left atrium and in the systemic circulation in patients with MS and sinus rhythm in the absence of LA thrombus. Successful BMV induces a significant reduction of prethrombotic status in patients with low LA pressure after the procedure. Patients with high LA pressure after BMV maintain a high prethrombotic state and may be considered at an increased risk of thromboembolism after the procedure.

Adolescent↗
PubMed1976

[Mitral stenosis and partial abnormal pulmonary venous return. 3 case reports].

The association of mitral stenosis with an abnormal pulmonary venous return in the absence of an atrial septal defect, is a rare occurrence, and three cases are reported here. If this diagnosis is suggested by the chest Xray, it is confirmed by haemodynamic investigation, which defines the abnormal pulmonary drainage, guages the size of the left-right shunt, and demonstrates the degree of mitral steonsis. If the defect is poorly tolerated, surgical treatment is required.

Aged↗
PubMed2006

Increased prevalence of mitral stenosis in women.

INTRODUCTION: The reported data in regard to increased prevalence of mitral stenosis (MS) in women are contradictory. The goal of this study was to investigate the sex-specific prevalence of MS as a surrogate for rheumatic heart disease. METHODS: We retrospectively analyzed 24,265 echocardiograms performed at our institution between 1984 and 1998. The prevalence of MS as a surrogate of rheumatic heart disease was calculated based on sex. As a control, the prevalence of mitral regurgitation was evaluated in both sexes. RESULTS: Echocardiograms were performed on 12,926 female (53%) and 11,339 male (47%) patients. MS was significantly more prevalent in women (1.6% vs 0.4%, P < .001). The prevalence of mitral regurgitation was similar between the two sexes (24.4% in women vs 25% in men). CONCLUSION: Our study is the largest to date to find increased prevalence of MS in women. The cause of this association is not known.

California↗